Antimicrobial Resistance in Community Healthcare

Main Article Content

Mr. Rohan Iyer

Abstract


Antimicrobial resistance (AMR) threatens the effectiveness of routine infection treatment and increases preventable illness, death and healthcare costs. Community healthcare is a critical setting because primary-care consultations, retail pharmacies, household practices and local transmission shape a large share of antimicrobial exposure. This article reviews the drivers of AMR in community settings and presents a practical stewardship framework for safer prescribing, prevention and surveillance. Key pressures include diagnostic uncertainty, antibiotics used for viral illness, unnecessary broad-spectrum treatment, non-prescription access, weak adherence to professionally directed regimens, poor infection prevention, and transmission across human, animal and environmental systems. Effective responses combine guideline-concordant prescribing, communication and delayed prescriptions where clinically appropriate, audit and feedback, rapid diagnostics, vaccination, water and sanitation measures, pharmacy engagement and locally linked resistance data. Programme evaluation should measure prescribing quality together with patient safety, access and clinical outcomes. Community stewardship is therefore not simply antibiotic restriction; it is a coordinated system for delivering the right treatment while reducing avoidable selection and spread of resistance.


Article Details

Section

Articles

References

1. World Health Organization. Antimicrobial resistance. Fact sheet. Geneva: WHO; 16 July 2026. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

2. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0.

3. World Health Organization. Global antibiotic resistance surveillance report 2025. Geneva: WHO; 2025. https://www.who.int/publications/i/item/9789240116337

4. World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva: WHO; 2022. https://www.who.int/publications/i/item/9789240062382

5. Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep. 2016;65(6):1–12. doi:10.15585/mmwr.rr6506a1.

6. Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793–798. doi:10.1016/j.cmi.2017.08.026.

7. Meeker D, Knight TK, Friedberg MW, et al. Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial. JAMA Intern Med. 2014;174(3):425–431. doi:10.1001/jamainternmed.2013.14191.

8. Meeker D, Linder JA, Fox CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices. JAMA. 2016;315(6):562–570. doi:10.1001/jama.2016.0275.

9. Spurling GK, Dooley L, Clark J, Askew DA. Immediate versus delayed versus no antibiotics for respiratory infections. Cochrane Database Syst Rev. 2022;10:CD004417. doi:10.1002/14651858.CD004417.pub6.

10. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315(17):1864–1873. doi:10.1001/jama.2016.4151.

11. Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115(15):E3463–E3470. doi:10.1073/pnas.1717295115.

12. World Health Organization. Global action plan on antimicrobial resistance 2026–2036. Geneva: WHO; 2026. https://www.who.int/publications/m/item/global-action-plan-on-antimicrobial-resistance-2026-2036